Labshake search

1 - 50 of 8190 citations for trans 2 2 4 Bromophenyl 2 oxoethyl cyclohexane 1 carboxylic acid since 2020

• Accelerated cognitive decline in obese mouse model of Alzheimer’s disease is linked to sialic acid-driven immune deregulation

  Stefano Suzzi, et al., bioRxiv - Neuroscience 2022

  Quote: ... 4’,6-diamidino-2-phenylindole (1:10,000; Biolegend) was used.
• Dynamically stiffening biomaterials reveal age- and sex-specific differences in pulmonary arterial adventitial fibroblast activation

  Mikala C. Mueller, et al., bioRxiv - Bioengineering 2024

  Quote: ... 4′,6-diamidino-2-phenylindole (DAPI; BioLegend) was diluted 1:10,000 from a 5 mg mL-1 stock solution in deionized water ...
• The MS remyelinating drug bexarotene (an RXR agonist) promotes induction of human Tregs and suppresses Th17 differentiation in vitro

  Christof Gaunt, et al., bioRxiv - Immunology 2021

  Quote: ... anti-IL-4 antibody (2 ug/ml; clone MD-1, Biolegend), bexarotene (1 μM ...
• The ATP-exporting channel Pannexin-1 promotes CD8⁺ T cell effector and memory responses

  Trupti Vardam-Kaur, et al., bioRxiv - Immunology 2024

  Quote: ... or phosphorylated ERK1/2 (pERK1/2; Biolegend), cells were stained with surface markers then fixed with Paraformaldehyde 1% ...
• Molecular and functional diversity of distinct subpopulations of extracellular vesicles from stressed pancreatic beta cells: implications for autoimmunity

  Khem Raj Giri, et al., bioRxiv - Immunology 2020

  Quote: ... CD81 (Eat-2; 1:1000; BioLegend), CD9 (EM-04 ...
• SARS-CoV-2 Omicron boosting induces de novo B cell response in humans

  Wafaa B. Alsoussi, et al., bioRxiv - Immunology 2022

  Quote: ... CD32 (FUN-2, BioLegend, 1:100), CD64 (10.1 ...
• SARS-CoV-2 Omicron boosting induces de novo B cell response in humans

  Wafaa B. Alsoussi, et al., bioRxiv - Immunology 2022

  Quote: ... CD32 (FUN-2, BioLegend, 1:100), CD64 (10.1 ...
• SARS-CoV-2 Omicron boosting induces de novo B cell response in humans

  Wafaa B. Alsoussi, et al., bioRxiv - Immunology 2022

  Quote: ... CD32 (FUN-2, BioLegend, 1:100), CD64 (10.1 ...
• SARS-CoV-2 Omicron boosting induces de novo B cell response in humans

  Wafaa B. Alsoussi, et al., bioRxiv - Immunology 2022

  Quote: ... CD32 (FUN-2, BioLegend, 1:100), and CD64 (10.1 ...
• mRNA-based influenza vaccine expands breadth of B cell response in humans

  Hanover C. Matz, et al., bioRxiv - Immunology 2024

  Quote: ... CD32 (FUN-2, BioLegend, 1:100), CD64 (10.1 ...
• mRNA-based influenza vaccine expands breadth of B cell response in humans

  Hanover C. Matz, et al., bioRxiv - Immunology 2024

  Quote: ... CD32 (FUN-2, BioLegend, 1:100), CD64 (10.1 ...
• IL-1β Signalling Modulates T Follicular Helper and Regulatory Cells in Human Lymphoid Tissues

  Romain Vaineau, et al., bioRxiv - Immunology 2024

  Quote: ... IL-2 (BV605, 1/160, Biolegend). The cells were incubated for 40 minutes at 4°C ...
• Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein

  Sameer Kumar Malladi, et al., bioRxiv - Immunology 2024

  Quote: ... CD32 (FUN-2, BioLegend, 1:100), and CD64 (10.1 ...
• Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein

  Sameer Kumar Malladi, et al., bioRxiv - Immunology 2024

  Quote: ... CD32 (FUN-2, BioLegend, 1:100), and CD64 (10.1 ...
• Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein

  Sameer Kumar Malladi, et al., bioRxiv - Immunology 2024

  Quote: ... CD32 (FUN-2, BioLegend, 1:100), and CD64 (10.1 ...
• Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein

  Sameer Kumar Malladi, et al., bioRxiv - Immunology 2024

  Quote: ... CD32 (FUN-2, BioLegend, 1:100), CD64 (10.1 ...
• Regulatory T cell expansion by a highly CD25-dependent IL-2 mutein arrests ongoing autoimmunity

  Liliane Khoryati, et al., bioRxiv - Immunology 2020

  Quote: ... IL-2 immune complex (IL-2ic; mouse recombinant IL-2 + anti-IL-2 (JES6-1A12, BioLegend); molar ratio 2:1 ...
• Subset-specific and temporal control of effector and memory CD4+ T cell survival

  Sharmila Shanmuganad, et al., bioRxiv - Immunology 2023

  Quote: ... IL-2 (Biolegend), CD127 ...
• Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment

  Jacob Gadwa, et al., bioRxiv - Immunology 2024

  Quote: ... Bcl-2 (BioLegend) or Ki67 (BD Bioscience ...
• Senescence rewires microenvironment sensing to facilitate anti-tumor immunity

  Hsuan-An Chen, et al., bioRxiv - Cancer Biology 2022

  Quote: ... and cultured in presence of IL-2 (2 ng/ml; Biolegend), IL-7 (2.5 ng/ml ...
• Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8⁺ T cells to suppress anti-tumor immunity

  Joanne D. Tejero, et al., bioRxiv - Immunology 2024

  Quote: ... and 10 ng/mL recombinant mouse interleukin-2 (IL-2) (BioLegend); additionally ...
• G9a methyltransferase governs cell identity in the lung and is required for KRAS G12D tumor development and propagation

  Ariel Pribluda, et al., bioRxiv - Cancer Biology 2020

  Quote: ... Notch2 (Biolegend, 130714, HMN-2-35, 1:80), Notch3 (eBioescience ...
• The pluripotent stem cell-specific transcript ESRG is dispensable for human pluripotency

  Kazutoshi Takahashi, et al., bioRxiv - Cell Biology 2020

  Quote: ... TRA-2-49/6E (1:100, 358702, BioLegend), anti-AFP (1:200 ...
• Defective mitochondrial-lysosomal axis promotes extracellular vesicles release of mitochondrial components in Huntington’s Disease

  Margarida Beatriz, et al., bioRxiv - Neuroscience 2022

  Quote: ... anti-CD107b (LAMP-2) (1:250, #354301, BioLegend), anti-PINK1 (1:1000 ...
• Defective mitochondrial-lysosomal axis promotes extracellular vesicles release of mitochondrial components in Huntington’s Disease

  Margarida Beatriz, et al., bioRxiv - Neuroscience 2022

  Quote: ... anti-CD107b (LAMP-2) (1:100, #354301, BioLegend), anti-PINK1 (1:100 ...
• Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine

  Kevin J. Kramer, et al., bioRxiv - Immunology 2021

  Quote: ... IL-2 AlexaFluor 700 (Biolegend 500320, 1:150), granzyme b FITC (Biolegend 515403 ...
• Nfkbid is required for immunity and antibody responses to Toxoplasma gondii

  Scott P. Souza, et al., bioRxiv - Immunology 2021

  Quote: ... anti-CD138/Syndecan-1-BV650 (281-2, BioLegend), anti-mouse-CD267/TACI-AlexaFlour-647 (8F10 ...
• Mitochondrial Fatty Acid Synthesis and Mecr Regulate CD4⁺ T Cell Function and Oxidative Metabolism

  KayLee K. Steiner, et al., bioRxiv - Immunology 2024

  Quote: ... IL-2 PE-Cy5 (1:100 BioLegend, 50384), IL-4 PE-Cy7 (1:100 BioLegend ...
• Biases in the Parsortix® system observed with pancreatic cancer cell lines

  Nele Vandenbussche, et al., bioRxiv - Cancer Biology 2024

  Quote: ... Cadherin-2 (CDH2) (350812, Biolegend, dilution 1:200), CD49f (563706 ...
• Branched actin polymerization drives invasive protrusion formation to promote myoblast fusion during skeletal muscle regeneration

  Yue Lu, et al., bioRxiv - Developmental Biology 2024

  Quote: ... rat anti-MAC-2 (1:200; Biolegend; 125401), and rat anti-Laminin-2 (1:500 ...
• The generation of a Bcl11a lineage tracing mouse model

  Sara Pensa, Pentao Liu, Walid T. Khaled, bioRxiv - Developmental Biology 2021

  Quote: ... Cd49f-BV421 (Biolegend 313623, 2 µg ml−1, 1:100), Cd49b-AF488 (Biolegend ...
• cellPLATO: an unsupervised method for identifying cell behaviour in heterogeneous cell trajectory data

  Michael J. Shannon, et al., bioRxiv - Cell Biology 2023

  Quote: ... CD18 (clone CBR LFA-1/2, AF647, Biolegend, 1:100), and CD29 (clone TS2/16 ...
• Single cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine

  Suhas Sureshchandra, et al., bioRxiv - Immunology 2021

  Quote: ... IgD (IA6-2, BioLegend), CD27 (M-T271 ...
• Lateral plate mesoderm cell-based organoid system for NK cell regeneration from human pluripotent stem cells

  Dehao Huang, et al., bioRxiv - Immunology 2021

  Quote: ... TRAIL (Biolegend, RIK-2), FasL (Biolegend ...
• The NK receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells

  Sumit Sen Santara, et al., bioRxiv - Immunology 2021

  Quote: ... 2 μM monensin (BioLegend) and 3 μM brefeldin A (BD ...
• The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation

  Danielle Minns, et al., bioRxiv - Immunology 2020

  Quote: ... IL-2 (Biolegend, #431004) and IL-22 (Biolegend ...
• Systemic and mucosal mobilization of granulocyte subsets during lentivirus infection

  Rhianna Jones, et al., bioRxiv - Immunology 2021

  Quote: ... CD32 (FUN-2; BioLegend), CD95 (DX2 ...
• Regeneration of humoral immunity from pluripotent stem cells by defined transcription factors

  Qi Zhang, et al., bioRxiv - Immunology 2021

  Quote: ... CD138(281-2, BioLegend), CD38(90 ...
• Deep immune profiling of the maternal-fetal interface with mild SARS-CoV-2 infection

  Suhas Sureshchandra, et al., bioRxiv - Immunology 2021

  Quote: ... IgD (IA6-2, BioLegend), CD27 (M-T271 ...
• Circulating mast cell progenitors migrate to atopic dermatitis-like skin then adapt locally

  Yuki Honda Keith, et al., bioRxiv - Immunology 2022

  Quote: ... integrinβ2 (M18/2; BioLegend), IgE (R35-72 ...
• Integration of Avidity and Differentiation is enabled by CD8⁺ T-cell sensing of IFN-γ

  Lion F.K. Uhl, et al., bioRxiv - Immunology 2023

  Quote: ... IL-2 (Biolegend, #575404), IL-1β (Biolegend ...
• Type I interferon dynamics determines memory B cell epigenetic identity in chronic viral infection

  Lucy Cooper, et al., bioRxiv - Immunology 2023

  Quote: ... or 2 (Biolegend #155863) for 20 minutes at 4°C ...
• Novel Fas-TNFR chimeras that prevents Fas ligand-mediated kill and signals synergistically to enhance CAR T-cell efficacy

  Callum McKenzie, et al., bioRxiv - Synthetic Biology 2023

  Quote: ... IL-2 (Biolegend; 431804), CCL1 (R&D Systems ...
• Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-T_SCM cells using qCART, the Quantum pBac-based CAR-T system

  Peter S. Chang, et al., bioRxiv - Cancer Biology 2022

  Quote: ... and IL-2 (BioLegend) were quantified by ELISA according to manufacturer’s instructions.
• Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells

  Yuhao Shi, et al., bioRxiv - Cancer Biology 2023

  Quote: ... CD8b.2 (Biolegend, 140416), Granzyme B (Biolegend ...
• Lung Microbiome Intervention Attenuates Herpesvirus-Induced Post-HCT Pulmonary Fibrosis Through PD-L1 Upregulation on Dendritic Cells

  Joshua B. Perkins, et al., bioRxiv - Immunology 2024

  Quote: ... CD8a (Ly-2, BioLegend), and CCR6 (29-2L17 ...
• Impaired complement regulation drives chronic lung allograft dysfunction after lung transplantation

  Hrishikesh S. Kulkarni, et al., bioRxiv - Immunology 2024

  Quote: ... CD138 (281-2; Biolegend) CD38 (S21016F ...
• Extrafollicular responses are sufficient to drive initiation of autoimmunity and early disease hallmarks of lupus

  Lasse F. Voss, et al., bioRxiv - Immunology 2022

  Quote: ... CD138-PE clone 281-2 (142504, BioLegend, 1:500), CD169-PE clone 3D6.112 (142404 ...
• Spermidine/spermine N1-acetyltransferase controls tissue-specific regulatory T cell function in chronic inflammation

  Teresa Neuwirth, et al., bioRxiv - Immunology 2024

  Quote: ... anti-IL-2 PE (Biolegend, Cat: 340450, 1:50), anti-IL-17A APC (eBioscience ...
• Targeting GFPT2 to reinvigorate immunotherapy in EGFR-mutated NSCLC

  Luyao Ao, et al., bioRxiv - Cancer Biology 2024

  Quote: ... Panel 2: BV421-conjugated CD45 (1:100, 103133, Biolegend), PE/Cy7-conjugated CD3 (1:100 ...